Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Puren, A. J.
Right arrow Articles by Smith, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Puren, A. J.
Right arrow Articles by Smith, C.
(Chest. 1995;107:1342-1349.)
© 1995 American College of Chest Physicians

Patterns of Cytokine Expression in Community-Acquired Pneumonia

Adrian J. Puren MB, BCh1; Charles Feldman MB, BCh, PhD, FCCP2; Nerina Savage PhD1; Pieter J. Becker PhD3; and Clifford Smith MB, BCh, MMEd, FCCP2

1 From the Department of Medical Biochemistry, University of the Witwatersrand Medical School, South Africa
2 From the Department of Medicine, Hillbrow Hospital, University of the Witwatersrand Medical School, South Africa
3 From the Institute of Bio-Statistics of the Medical Research Council of South Africa, Johannesburg

Background: Pneumonia continues to be a major cause of disease and death among patients worldwide. Aspects of the host response to infection, such as the release of cytokines, may be contributing to the persistent morbidity and mortality.

Methods: Plasma levels of cytokines interleukin (IL)-1β, IL-6, and tumor necrosis factor alpha (TNF-agr) were measured in critically ill patients with pneumonia (ICUP; n=12) and less severely ill patients with pneumonia (NONICUP; n=8), and in 2 additional control groups of patients, viz, severely ill postoperative patients without evidence of infection (POSTOP; n=11) and less severely ill patients with nonpneumonia infections (NONP; n=9). All four groups of patients were studied in a multivariate one-way analysis of variance using the parameter vector: plasma IL-1β, IL-6, TNF-agr, systolic blood pressure, diastolic blood pressure, plasma urea, creatinine, and temperature. Thereafter the significance of individual parameters were assessed by univariate analysis and pairwise comparisons.

Results: All cytokine concentrations were highest in the ICUP group. In the case of IL-1β, levels were significantly higher in the ICUP group when compared with the noninfected POSTOP group. The acute physiology and chronic health evaluation (APACHE) II scores were identical in these two groups (17±3 [SD] and 10±1, respectively, not significantly different). Intermediate levels were found in those groups with intermediate levels of infection. The IL-6 levels were not significantly different between the groups and in particular, the levels in the ICUP and POSTOP groups were similar. The TNF-agr levels tended to mimic those of IL-lβ, although the significant difference found was between the ICUP and NONICUP groups which had significantly different APACHE II scores (17±3 vs 4.4±1, respectively). No association between cytokine levels and patient mortality was demonstrated.

Conclusion: Among the cytokines, IL-1β appeared to be associated with the severity of infection, IL-6 appears to reflect severity of stress whether of infection or noninfective origin, and TNF-agr may be a marker of severity of pneumonia.

Key Words: cytokine • interleukin-1 • interleukin-6 • pneumonia • tumor necrosis factor

Submitted on December 28, 1993
Accepted on August 17, 1994




This article has been cited by other articles:


Home page
ChestHome page
M. A. Martinez-Garcia, J.-J. Soler-Cataluna, M. Perpina-Tordera, P. Roman-Sanchez, and J. Soriano
Factors Associated With Lung Function Decline in Adult Patients With Stable Non-Cystic Fibrosis Bronchiectasis
Chest, November 1, 2007; 132(5): 1565 - 1572.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Confalonieri, R. Urbino, A. Potena, M. Piattella, P. Parigi, G. Puccio, R. Della Porta, C. Giorgio, F. Blasi, R. Umberger, et al.
Hydrocortisone Infusion for Severe Community-acquired Pneumonia: A Preliminary Randomized Study
Am. J. Respir. Crit. Care Med., February 1, 2005; 171(3): 242 - 248.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
N. Benito, A. Moreno, X. Filella, J. M. Miro, J. Gonzalez, T. Pumarola, M. E. Valls, M. Luna, F. Garcia, A. Rano, et al.
Inflammatory Responses in Blood Samples of Human Immunodeficiency Virus-Infected Patients with Pulmonary Infections
Clin. Vaccine Immunol., May 1, 2004; 11(3): 608 - 614.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
G. Antunes, S.A. Evans, J.L. Lordan, and A.J. Frew
Systemic cytokine levels in community-acquired pneumonia and their association with disease severity
Eur. Respir. J., October 1, 2002; 20(4): 990 - 995.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. C. Angus, T. J. Marrie, D. S. Obrosky, G. Clermont, T. T. Dremsizov, C. Coley, M. J. Fine, D. E. Singer, and W. N. Kapoor
Severe Community-acquired Pneumonia: Use of Intensive Care Services and Evaluation of American and British Thoracic Society Diagnostic Criteria
Am. J. Respir. Crit. Care Med., September 1, 2002; 166(5): 717 - 723.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
U K Kolling, F Hansen, J Braun, L Rink, H A Katus, and K Dalhoff
Leucocyte response and anti-inflammatory cytokines in community acquired pneumonia
Thorax, February 1, 2001; 56(2): 121 - 125.
[Abstract] [Full Text]


Home page
Antimicrob. Agents Chemother.Home page
M. Duong, M. Simard, Y. Bergeron, and M. G. Bergeron
Kinetic Study of the Inflammatory Response in Streptococcus pneumoniae Experimental Pneumonia Treated with the Ketolide HMR 3004
Antimicrob. Agents Chemother., January 1, 2001; 45(1): 252 - 262.
[Abstract] [Full Text]


Home page
J. Nutr.Home page
M. J. Manary, K. E. Yarasheski, C. A. Hart, and R. L. Broadhead
Plasma Urea Appearance Rate Is Lower When Children with Kwashiorkor and Infection Are Fed Egg White-Tryptophan Rather than Milk Protein
J. Nutr., January 1, 2000; 130(2): 183 - 188.
[Abstract] [Full Text]


Home page
ThoraxHome page
J R Catterall
Lung infections bullet 5: Streptococcus pneumoniae
Thorax, October 1, 1999; 54(10): 929 - 937.
[Full Text]


Home page
CVIHome page
T. Matsumoto, K. Tateda, S. Miyazaki, N. Furuya, A. Ohno, Y. Ishii, Y. Hirakata, and K. Yamaguchi
Effect of Antiflagellar Human Monoclonal Antibody on Gut-Derived Pseudomonas aeruginosa Sepsis in Mice
Clin. Vaccine Immunol., July 1, 1999; 6(4): 537 - 541.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
P Glynn, R Coakley, I Kilgallen, N Murphy, and S O'Neill
Circulating interleukin 6 and interleukin 10 in community acquired pneumonia
Thorax, January 1, 1999; 54(1): 51 - 55.
[Abstract] [Full Text]


Home page
Antimicrob. Agents Chemother.Home page
M. Duong, M. Simard, Y. Bergeron, N. Ouellet, M. Côté-Richer, and M. G. Bergeron
Immunomodulating Effects of HMR 3004 on Pulmonary Inflammation Caused by Heat-Killed Streptococcus pneumoniae in Mice
Antimicrob. Agents Chemother., December 1, 1998; 42(12): 3309 - 3312.
[Abstract] [Full Text]


Home page
Antimicrob. Agents Chemother.Home page
Y. Bergeron, N. Ouellet, A.-M. Deslauriers, M. Simard, M. Olivier, and M. G. Bergeron
Reduction by Cefodizime of the Pulmonary Inflammatory Response Induced by Heat-Killed Streptococcus pneumoniae in Mice
Antimicrob. Agents Chemother., October 1, 1998; 42(10): 2527 - 2533.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
L. S. NIXON, B. YUNG, S. C. BELL, J. STUART ELBORN, and D. J. SHALE
Circulating Immunoreactive Interleukin-6 in Cystic Fibrosis
Am. J. Respir. Crit. Care Med., June 1, 1998; 157(6): 1764 - 1769.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
Y. Bergeron, N. Ouellet, A.-M. Deslauriers, M. Simard, M. Olivier, and M. G. Bergeron
Cytokine Kinetics and Other Host Factors in Response to Pneumococcal Pulmonary Infection in Mice
Infect. Immun., March 1, 1998; 66(3): 912 - 922.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American College of Chest Physicians.